India vs South-East Asia (WHO region): Confirmed cases of RR-/MDR-TB
India
55,447
in 2024
South-East Asia (WHO region)
61,774
in 2024
India rank
1st
South-East Asia (WHO region) rank
3rd
Confirmed cases of RR-/MDR-TB over time
- India
- South-East Asia (WHO region)
How they compare
South-East Asia (WHO region) currently reports 61,774 against 55,447 in India, a difference of 6,327.
That makes South-East Asia (WHO region)'s figure about 1.1 times India's.
Across all 20 years both countries report, South-East Asia (WHO region) has been ahead every year.
India ranks 1st and South-East Asia (WHO region) ranks 3rd of 195 countries.
South-East Asia (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 444 | 1,121 | 676.6 | South-East Asia (WHO region) |
| 2010s | 30,349 | 35,578 | 5,229 | South-East Asia (WHO region) |
| 2020s | 58,594 | 65,136 | 6,542 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of rr-/mdr-tb, India or South-East Asia (WHO region)?
- South-East Asia (WHO region), at 61,774 against 55,447 in India as of 2024.
- What is the difference in confirmed cases of rr-/mdr-tb between India and South-East Asia (WHO region)?
- 6,327, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for India and South-East Asia (WHO region)?
- 20 years are reported by both, from 2005 to 2024.
- How do India and South-East Asia (WHO region) rank globally for confirmed cases of rr-/mdr-tb?
- India ranks 1st and South-East Asia (WHO region) ranks 3rd of 195 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of RR-/MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.